Sort   by:  
 Page size 
UnknownAwareness and agreement with neurofibromatosis care guidelines among U.S. neurofibromatosis specialists.
Not available
S-EPMC8832755 | biostudies-literature
UnknownSelf-reported access to specialty clinics and receipt of health surveillance among U.S. patients with neurofibromatosis 1: a national survey.
Not available
S-EPMC12004880 | biostudies-literature
UnknownPhase II study of axitinib in patients with <i>NF2</i>-related schwannomatosis and progressive vestibular schwannomas.
Not available
S-EPMC12199335 | biostudies-literature
UnknownBrain Region-Specific Degeneration with Disease Progression in Late Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease).
Not available
S-EPMC4907890 | biostudies-literature
UnknownDisease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study.
Not available
S-EPMC7516285 | biostudies-literature
UnknownSlowing late infantile Batten disease by direct brain parenchymal administration of a rh.10 adeno-associated virus expressing CLN2.
Not available
S-EPMC8056991 | biostudies-literature
UnknownManagement of neurofibromatosis type 1-associated plexiform neurofibromas.
Not available
S-EPMC9629437 | biostudies-literature
UnknownMEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.
Not available
S-EPMC9629420 | biostudies-literature
UnknownWireless sensors for continuous, multimodal measurements at the skin interface with lower limb prostheses.
Not available
S-EPMC7775724 | biostudies-literature
UnknownCLIN-PEDIATRICS CLINICAL RESEARCH
Not available
S-EPMC3488788 | biostudies-literature
Sort   by:  
 Page size